| # | Drug | Count |
|---|---|---|
| 0 | CAPECITABINE | 46 |
| 1 | FULVESTRANT | 39 |
| 2 | LETROZOLE | 30 |
| 3 | PALBOCICLIB | 30 |
| 4 | PACLITAXEL | 27 |
| 5 | LETROZOLE TABLETS | 26 |
| 6 | PACLITAXEL (AIBUMIN-BOUND) | 26 |
| 7 | OCTREOTIDE ACETATE | 24 |
| 8 | BEVACIZUMAB | 17 |
| 9 | EVEROLIMUS | 17 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ERIBULIN MESYLATE | 7 | 0.0019 |
| 1 | TEBENTAFUSP | 1 | 0.0017 |
| 2 | MAGNESIUM SALICYLATE | 1 | 0.0017 |
| 3 | TROPICAMIDE | 2 | 0.0012 |
| 4 | FULVESTRANT | 39 | 0.0012 |
| 5 | OXAPROZIN | 1 | 0.0011 |
| 6 | TAMOXIFEN CITRATE | 5 | 0.0009 |
| 7 | OCTREOTIDE ACETATE | 24 | 0.0008 |
| 8 | AFATINIB | 5 | 0.0008 |
| 9 | GOSERELIN | 9 | 0.0007 |
| # | Drug class | Count |
|---|---|---|
| 0 | Kinase Inhibitor [EPC] | 71 |
| 1 | Nucleoside Metabolic Inhibitor [EPC] | 52 |
| 2 | Aromatase Inhibitor [EPC] | 42 |
| 3 | Estrogen Receptor Antagonist [EPC] | 39 |
| 4 | Microtubule Inhibitor [EPC] | 30 |
| 5 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 19 |
| 6 | Platinum-based Drug [EPC] | 18 |
| 7 | mTOR Inhibitor Immunosuppressant [EPC] | 17 |
| 8 | Alkylating Drug [EPC] | 13 |
| 9 | Corticosteroid [EPC] | 12 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC] | 1 | 0.0017 |
| 1 | Estrogen Receptor Antagonist [EPC] | 39 | 0.0010 |
| 2 | alpha-1 Adrenergic Agonist [EPC] | 3 | 0.0007 |
| 3 | Aromatase Inhibitor [EPC] | 42 | 0.0004 |
| 4 | CD22-directed Immunoconjugate [EPC] | 1 | 0.0003 |
| 5 | Nucleoside Metabolic Inhibitor [EPC] | 52 | 0.0002 |
| 6 | Microtubule Inhibitor [EPC] | 30 | 0.0002 |
| 7 | Somatostatin Analog [EPC] | 1 | 0.0001 |
| 8 | Provitamin D2 Compound [EPC] | 4 | 0.0001 |
| 9 | HER2/neu Receptor Antagonist [EPC] | 10 | 0.0001 |